BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30
• 31

• RaeSedo Selected to Present New Approach to Asthma Treatment at the 2024 ATS Respiratory Innovation Summit

  RaeSedo, Inc. today announced that it will present its pioneering approach to asthma treatment as a showcase company at the 2024 American Thoracic Society (ATS) Respiratory Innovation Summit (RIS).

  May 15, 2024

   · 

  6 min read
• Drug Development

  CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP)

  CASI Pharmaceuticals, Inc. announced today the following: On April 12, 2024 CASI submitted the IND application to the FDA for CID-103 to support a phase 1/2 study of CID-103 in adults with chronic Immune Thrombocytopenia (ITP).

  May 15, 2024

   · 

  5 min read
• Business

  Intensity Therapeutics, Inc. Announces the Appointment of Thomas Dubin to Its Board of Directors

  Intensity Therapeutics, Inc. announces the appointment of Thomas Dubin, J.D., MPH, to the Intensity Board of Directors, effective May 14, 2024.

  May 15, 2024

   · 

  6 min read
• Business

  TriSalus Reports Q1 2024 Financial Results and Business Update

  TriSalus Life Sciences Inc., announced its financial results for the first quarter ended March 31, 2024, and provided a business update.

  May 15, 2024

   · 

  10 min read
• Gate Neurosciences to Share New Data and Research Insights on its Synaptic Function Molecules with Multiple Posters at 2024 ASCP Annual Meeting

  Gate Neurosciences today announced upcoming activities at the 2024 annual meeting of the American Society of Clinical Psychopharmacology (ASCP), being held in Miami Beach, FL, from May 28-31, 2024.

  May 15, 2024

   · 

  4 min read
• Business

  Aulos Bioscience Enters Into Clinical Trial Collaboration and Supply Agreement With Merck KGaA, Darmstadt, Germany To Study Combination of Bavencio® With AU-007

  Aulos Bioscience today announced a new collaboration and supply agreement with Ares Trading S.A., a Swiss subsidiary of Merck KGaA, Darmstadt, Germany, for use of Bavencio® (avelumab) in a clinical study of its lead human monoclonal antibody candidate, AU-007.

  May 15, 2024

   · 

  4 min read
• Business

  BioAge Labs Announces Inaugural Scientific Advisory Board to Support Advancement of Novel Therapeutics Targeting Metabolic Aging

  BioAge Labs, Inc. today announced the formation of its Scientific Advisory Board (SAB).

  May 15, 2024

   · 

  5 min read
• Pharm Country

  Virpax Announces Pricing of $2.25 Million Public Offering

  The closing of the offering is expected to occur on or about May 17, 2024, subject to the satisfaction of customary closing conditions.

  May 15, 2024

   · 

  5 min read
• BioMidwest

  AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

  AtriCure, Inc. today announced that the company will be participating in the upcoming Leerink Partners Healthcare Crossroads Conference.

  May 15, 2024

   · 

  1 min read
• Biotech Beach

  Aspen Neuroscience Receives CLIN2 Grant for ANPD001 from California Institute for Regenerative Medicine (CIRM)

  Aspen Neuroscience, Inc. has received a CLIN2 grant award of $8 million from the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative medicine, to support clinical research aimed at treating Parkinson’s disease (PD).

  May 15, 2024

   · 

  4 min read